Phase II/III Study of YM150 - A Placebo-Controlled, Double-Blind, Group Comparison Study in Patients Undergoing Elective Total Hip Replacement Surgery.
Phase of Trial: Phase II/III
Latest Information Update: 01 Mar 2014
At a glance
- Drugs Darexaban (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 08 Jun 2010 Actual end date added 1 Mar 2010 as reported by ClinicalTrials.gov.
- 08 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2010 Actual patient number (610) added as reported by ClinicalTrials.gov.